Odyssey Long Term Trial - Dr. Milan Chag
ODYSSEY long term | Professor Jennifer Robinson
ACC 2019: ODYSSEY OUTCOMES Trial - Prof Vera Bittner
Can You Discuss the ODYSSEY Trial Results?
Pushing the Envelope with PCSK9-Twenty Years of Progress
Exciting Future of the ODYSSEY Trial - Medpage Today
Professor Jennifer Robinson (Iowa City, USA):
ESC TV at ACC.18 - Results from the ODYSSEY Outcomes Trial
Jay Edelberg, MD, PhD, Talks Trial Results for Alirocumab (Praluent)
The Oddessy of PCSK9 Inhibitors: What Might it Mean for Guidelines?
EHJ Today - The ODYSSEY ALTERNATIVE Trial
AHA 2014 | ODYSSEY LONG TERM
OSLER Trials Suggest PCSK9 Inhibitor Reduces Cardiovascular Events Long Term
ACC.18 | ODYSSEY Outcomes
ODYSSEY HeFH long term data | Professor Eric Bruckert
LDL-C: How Low Should We Go?
Dr. Christopher Cannon comments on the results of ODYSSEY COMBO-II trial
ODYSSEY trials at ESC Congress Hotline | Professor Alberto Zambon
OfficePerspectives PCSK9
Best of ESC Congress 2014 - 04 sept 2014